Top

Archives of Gynecology and Obstetrics

Published in:

01-12-2015 | Review

Use of misoprostol in myomectomy: a systematic review and meta-analysis

Authors: Christos Iavazzo, Ioannis Mamais, Ioannis D. Gkegkes

Published in: Archives of Gynecology and Obstetrics | Issue 6/2015

Abstract

Introduction

Misoprostol, a prostaglandin derivative, reduces blood flow to uterus, facilitating every surgical operation on myometrium.

Method

PubMed, Scopus and Cochrane databases were systematically searched and five studies met the inclusion criteria for our meta-analysis.

Results

In total, 283 patients were included. The intention to treat population included 142 patients. The mean age of the patients was 34 years old. The vaginal route of administration was preferred in 117 out of 142 patients and the rectal route in 25 patients. Three studies were included in the analysis regarding duration of operation, estimated blood loss, preoperative/postoperative hemoglobin, transfusions needed and febrile morbidity. No significant difference was observed between vaginal suppository and placebo group concerning the duration of operation, the fall of preoperative hemoglobin, transfusions needed and the febrile morbidity. Regarding the estimated blood loss, the mean difference observed between the misoprostol and placebo groups was −148.55 mL per operation (95 % CI, −233.10 to −64), p < 0.001. As far as the postoperative Hgb, the misoprostol group presented significantly smaller reduction, 0.68 gr/dL per operation (95 % CI, 0.38–0.97), p < 0.001.

Conclusion

Easy to use, minor or no side effects, and good clinical outcomes are the properties that render misoprostol useful in the realization myomectomy independently of the surgical technique applied.

Tang OS, Gemzell-Danielsson K, Ho PC (2007) Misoprostol: pharmacokinetic profiles, effects on the uterus and side-effects. Int J Gynaecol Obstet 99(Suppl 2):S160–S167CrossRefPubMed

Choksuchat C (2010) Clinical use of misoprostol in nonpregnant women: review article. J Minim Invasive Gynecol 17:449–455CrossRefPubMed

Goldberg AB, Carusi DA, Meckstroth KR (2003) Misoprostol in gynecology. Curr Womens Health Rep 3:475–483PubMed

Hofmeyr GJ, Walraven G, Gulmezoglu AM, Maholwana B, Alfirevic Z, Villar J (2005) Misoprostol to treat postpartum haemorrhage: a systematic review. BJOG 112:547–553CrossRefPubMed

Brown SE, Toner JP, Schnorr JA et al (2001) Vaginal misoprostol enhances intrauterine insemination. Hum Reprod 16:96–101CrossRefPubMed

Kongnyuy EJ, Wiysonge CS (2014) Interventions to reduce haemorrhage during myomectomy for fibroids. Cochrane Database Syst Rev 8:CD005355

Yip SK, Tse AO, Haines CJ, Chung TK (2000) Misoprostol’s effect on uterine arterial blood flow and fetal heart rate in early pregnancy. Obstet Gynecol 95:232–235CrossRefPubMed

Celik H, Sapmaz E (2003) Use of a single preoperative dose of misoprostol is efficacious for patients who undergo abdominal myomectomy. Fertil Steril 79:1207–1210CrossRefPubMed

Jadad AR, Moore RA, Carroll D et al (1996) Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials 17:1–12CrossRefPubMed

10.

Moher D, Pham B, Jones A et al (1998) Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses? Lancet 352:609–613CrossRefPubMed

11.

Niroomand N, Hajiha S, Tabrizi NM, Ghajarzadeh M. A single dose of misoprostol for reducing hemorrhage during myomectomy: a randomized clinical trial. Arch Gynecol Obstet 2015

12.

Ragab A, Khaiary M, Badawy A (2014) The Use of single versus double dose of intra-vaginal prostaglandin E2 “misoprostol” prior to abdominal myomectomy: a randomized controlled clinical trial. J Reprod Infertil 15:152–156PubMedCentralPubMed

13.

Frederick S, Frederick J, Fletcher H, Reid M, Hardie M, Gardner W (2013) A trial comparing the use of rectal misoprostol plus perivascular vasopressin with perivascular vasopressin alone to decrease myometrial bleeding at the time of abdominal myomectomy. Fertil Steril 100:1044–1049CrossRefPubMed

14.

Kalogiannidis I, Xiromeritis P, Prapas N, Prapas Y (2011) Intravaginal misoprostol reduces intraoperative blood loss in minimally invasive myomectomy: a randomized clinical trial. Clin Exp Obstet Gynecol 38:46–49PubMed

15.

Agostini A, Ronda I, Franchi F et al (2005) Oxytocin during myomectomy: a randomized study. Eur J Obstet Gynecol Reprod Biol 118:235–238CrossRefPubMed

16.

Ikechebelu JI, Ezeama CO, Obiechina NJ (2010) The use of torniquet to reduce blood loss at myomectomy. Niger J Clin Pract 13:154–158PubMed

17.

Shokeir T, Shalaby H, Nabil H, Barakat R (2013) Reducing blood loss at abdominal myomectomy with preoperative use of dinoprostone intravaginal suppository: a randomized placebo-controlled pilot study. Eur J Obstet Gynecol Reprod Biol 166:61–64CrossRefPubMed

18.

Vercellino G, Erdemoglu E, Joe A et al (2012) Laparoscopic temporary clipping of uterine artery during laparoscopic myomectomy. Arch Gynecol Obstet 286:1181–1186CrossRefPubMed

19.

Benassi L, Lopopolo G, Pazzoni F et al (2000) Chemically assisted dissection of tissues: an interesting support in abdominal myomectomy. J Am Coll Surg 191:65–69CrossRefPubMed

20.

Lumsden MA (2002) Embolization versus myomectomy versus hysterectomy: which is best, when? Hum Reprod 17:253–259CrossRefPubMed

21.

Mousa HA, Blum J, Abou El Senoun G, Shakur H, Alfirevic Z (2014) Treatment for primary postpartum haemorrhage. Cochrane Database Syst Rev 2:CD003249

22.

Law KS, Abbott JA, Lyons SD (2014) Energy sources for gynecologic laparoscopic surgery: a review of the literature. Obstet Gynecol Surv 69:763–776CrossRefPubMed

Title: Use of misoprostol in myomectomy: a systematic review and meta-analysis
Authors: Christos Iavazzo
Ioannis Mamais
Ioannis D. Gkegkes
Publication date: 01-12-2015
Publisher: Springer Berlin Heidelberg
Published in: Archives of Gynecology and Obstetrics / Issue 6/2015
Print ISSN: 0932-0067
Electronic ISSN: 1432-0711
DOI: https://doi.org/10.1007/s00404-015-3779-x

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Use of misoprostol in myomectomy: a systematic review and meta-analysis

Abstract

Introduction

Method

Results

Conclusion

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Introduction

Method

Results

Conclusion

Please log in to get access to this content

Other articles of this Issue 6/2015

Visualisation of the vascular equator in twin-to-twin transfusion syndrome by virtual fetoscopy

Cyclic versus continuous medroxyprogesterone acetate for treatment of endometrial hyperplasia without atypia: a 2-year observational study

Therapy and differential diagnosis of posterior reversible encephalopathy syndrome (PRES) during pregnancy and postpartum

Cesarean section and the risk of emergency peripartum hysterectomy in high-income countries: a systematic review

Systematic pelvic and paraaortic lymphadenectomy in early high-risk or advanced endometrial cancer

To do or not to do emergency cervical cerclage (a rescue stitch) at 24–28 weeks gestation in addition to progesterone for patients coming early in labor? A prospective randomized trial for efficacy and safety